Leo Kunz

Basel, BS, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

FAP-CD40 and PD1-IL2v combination therapy reprograms immunologically cold tumors through de novo intratumoral T cell-dendritic cell clusters.

FAP-CD40 and PD1-IL2v combination therapy reprograms immunologically cold tumors through de novo intratumoral T cell-dendritic cell clusters.

Journal: Journal for immunotherapy of cancer
Published: May 14, 2026

FAP-Targeted LTβR Agonist Drives HEV Differentiation and Immune Niche Formation for Improved Immunotherapy Response in Solid Tumors.

FAP-Targeted LTβR Agonist Drives HEV Differentiation and Immune Niche Formation for Improved Immunotherapy Response in Solid Tumors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 23, 2025

Points to Consider From the ESTP Pathology 2.0 Working Group: Overview on Spatial Omics Technologies Supporting Drug Discovery and Development.

Points to Consider From the ESTP Pathology 2.0 Working Group: Overview on Spatial Omics Technologies Supporting Drug Discovery and Development.

Journal: Toxicologic pathology
Published: February 11, 2025

Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myeloma.

Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myeloma.

Journal: Blood
Published: July 10, 2024

CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy.

CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy.

Journal: Blood
Published: November 27, 2023

B- and T-cell acute lymphoblastic leukemias evade chemotherapy at distinct sites in the bone marrow.

B- and T-cell acute lymphoblastic leukemias evade chemotherapy at distinct sites in the bone marrow.

Journal: Haematologica
Published: December 02, 2021

An In Vivo CRISPR Screen Identifies Stepwise Genetic Dependencies of Metastatic Progression.

An In Vivo CRISPR Screen Identifies Stepwise Genetic Dependencies of Metastatic Progression.

Journal: Cancer research
Published: November 14, 2021

Multicolor 3D Confocal Imaging of Thick Tissue Sections.

Multicolor 3D Confocal Imaging of Thick Tissue Sections.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 31, 2021

Multi-Parameter Quantitative Imaging of Tumor Microenvironments Reveals Perivascular Immune Niches Associated With Anti-Tumor Immunity.

Multi-Parameter Quantitative Imaging of Tumor Microenvironments Reveals Perivascular Immune Niches Associated With Anti-Tumor Immunity.

Journal: Frontiers in immunology
Published: June 17, 2021

Intercrypt sentinel macrophages tune antibacterial NF-κB responses in gut epithelial cells via TNF.

Intercrypt sentinel macrophages tune antibacterial NF-κB responses in gut epithelial cells via TNF.

Journal: The Journal of experimental medicine
Published: April 21, 2021

PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cells.

PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cells.

Journal: Nature
Published: March 14, 2021

Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor Immunity.

Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor Immunity.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 11, 2020
Showing 1-12 of 26

Last Updated: 09/26/2026